| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.58T | 3.67T | 3.61T | 3.99T | 2.71T | 2.94T |
| Gross Profit | 226.49B | 530.64B | 618.42B | 342.65B | 185.70B | 387.75B |
| EBITDA | 355.78B | 412.42B | 526.78B | 273.59B | 145.05B | 337.66B |
| Net Income | 237.51B | 202.09B | 403.14B | 38.23B | -43.02B | 147.20B |
Balance Sheet | ||||||
| Total Assets | 7.50T | 7.12T | 7.11T | 6.46T | 6.17T | 5.69T |
| Cash, Cash Equivalents and Short-Term Investments | 352.43B | 293.55B | 390.81B | 361.32B | 203.21B | 176.46B |
| Total Debt | 3.27T | 3.10T | 2.98T | 2.91T | 2.79T | 2.40T |
| Total Liabilities | 4.42T | 4.27T | 4.41T | 4.29T | 4.05T | 3.58T |
| Stockholders Equity | 3.01T | 2.79T | 2.59T | 2.06T | 2.02T | 2.03T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 28.80B | 95.41B | 46.75B | -210.47B | 172.21B |
| Operating Cash Flow | 0.00 | 301.35B | 344.07B | 295.80B | 21.69B | 384.15B |
| Investing Cash Flow | 0.00 | -391.77B | -388.33B | -196.93B | -262.02B | -215.81B |
| Financing Cash Flow | 0.00 | -27.65B | 87.08B | 73.25B | 266.40B | -141.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥2.70T | 6.37 | 14.42% | 2.44% | 2.08% | 19.52% | |
74 Outperform | ¥857.05B | 5.24 | 16.95% | 3.00% | 5.81% | 102.00% | |
72 Outperform | ¥2.61T | 14.41 | 11.05% | 1.53% | 5.72% | 148.08% | |
67 Neutral | ¥2.10T | 12.59 | 8.26% | 2.75% | 3.26% | -7.07% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
63 Neutral | ¥2.49T | 11.58 | 10.44% | 1.98% | 1.99% | 95.71% | |
52 Neutral | ¥1.04T | 5.29 | -22.13% | ― | -2.28% | -794.92% |